The article presents information on the pharmaceutical companies manufacturing brand-name drugs and the issues related to pharmaceutical sales representative (PSR). The intensive sales training program, the exempt from overtime pay based on the U.S. Fair Labor Standards Act and the economic justice and security of low income group are discussed. The court decision of Smith v. Johnson & Johnson, white-collar exemptions and employee misclassification are also discussed.
Prescription for Change: Third Circuit Diagnoses Pharmaceutical Sales Representatives as Exempt from Overtime Pay in Smith v. Johnson & Johnson,
Vill. L. Rev.
Available at: http://digitalcommons.law.villanova.edu/vlr/vol56/iss4/1